TRUST ATLAS WORKSHEET
Performance evaluation file
EU in vitro diagnostics · Step 2 · Plan and generate performance evidence- Who prepares it
- Clinical + analytical performance teams
- When to prepare it
- Before conformity assessment
Worked example
This example uses fictional details. Use the same fields with evidence from your work.
- Claim
- Measure the specified analyte in the declared sample type for the approved use.
- Scientific validity
- Link evidence connecting the analyte to the condition or state.
- Analytical performance
- Link reproducibility and interference reports for the declared device configuration.
- Clinical performance
- Link the evaluation in the intended population and note evidence limits.
- Review and follow-up
- Clinical and regulatory leads confirm claim wording and post-market work.
Gather first
- Approved IVD intended purpose and claims
- Scientific, analytical and clinical evidence
- Current performance evaluation plan and risk file
How to prepare it
- Turn each claim into a row with analyte, specimen, population and setting. Identify which data support scientific validity, analytical performance and clinical performance.
- Link to study design and results, including limitations, biases and deviations. Reconcile all test, assay and software revisions with the intended claim.
- Explain how the evidence supports each claim. Record review and remaining issues, and plan post-market performance follow-up where applicable.
Review
A reviewer can follow a claim from label to evidence and see what was excluded or remains uncertain.
Handoff
Give the approved performance evaluation to regulatory affairs, quality and the notified body where required.